Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
From their beginnings as a treatment for type 2 diabetes, GLP-1 receptor agonists such as semaglutide and tirzepatide have seen an explosion in use, most popularly for weight loss
Composition BPC-157: 5 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment Assay development and calibration for quantitative analysis Chromatographic method optimization for impurity profiling Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
As per Bloomberg , Aspen is targeting regulatory approval in Canada between May and September for its generic GLP1 obesity treatment and expects Canada will likely be the first market for its GLP1 product
Those who wish to support healing of tendons, ligaments, skin, or bones
Graf WD, Marin-Garcia J, Gao HG, Pizzo S, Naviaux RK, Markusic D et al
A long-term, randomised, double-blind, placebo-controlled study
US$ 21.33
US$ 24.73
US$ 23.59
